GlassScriptPhysician profile
Tonya L Howell
NPI 1952689192
$2,860.00
in general payments reported to CMS, 2019-2025
23 companies · $782 in 2025
The $782 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $386 · 2022: $587 · 2023: $365 · 2024: $740 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,886.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $432.24 | 2021-2025 | |
| Scpharmaceuticals INC. | $320.09 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.47 | 2022-2025 | Jardiance |
| Boston Scientific Corporation | $293.21 | 2022-2025 | Rhythmia Mapping System, Watchman Access System, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.35 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $209.17 | 2021-2025 | Camzyos |
| Pfizer INC. | $156.75 | 2021-2025 | |
| Amgen INC. | $142.19 | 2021-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $126.32 | 2021-2022 | |
| Medtronic, INC. | $111.54 | 2021-2025 | Linq II |
| Astrazeneca Pharmaceuticals LP | $83.67 | 2021-2024 | Farxiga |
| Merck Sharp & Dohme LLC | $80.80 | 2021-2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $59.10 | 2022-2023 | Assure Wcd |
| G Medical Diagnostic Services, INC. | $45.78 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $45.49 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $37.11 | 2022-2024 | |
| Edwards Lifesciences Corporation | $36.11 | 2023 | |
| Irhythm Technologies, INC. | $33.57 | 2021-2022 | |
| Cardiovascular Systems INC. | $28.45 | 2021 | |
| Novo Nordisk INC | $23.31 | 2025 | Wegovy |
| Abbott Laboratories | $20.26 | 2025 | Navitor |
| Amarin Pharma, INC. | $18.82 | 2022 | |
| Amryt Pharma Holdings LTD | $14.20 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tonya Howell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.